BeiGene announced the first major step in the company’s expansion in Latin America with the formal opening of its office in Sao Paulo, Brazil. The Sao Paulo office will house BeiGene administrative, commercial, and clinical operations colleagues in Brazil, which is the largest oncology market in LATAM with approximately 53% of all patients in the region.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BGNE:
- Enlivex, BeiGene enter clinical collaboration agreement
- BeiGene price target raised to $263.30 from $230.10 at BofA
- Enlivex Therapeutics provides business updates on clinical programs
- Enlivex, BeiGene collaborate to evaluate Allocetra with Tislelizumab
- J.P. Morgan Analysts Say These 2 Stocks Are Their Top Picks for 2023
